How Much Bacteriostatic Water for GHK-Cu? (Chart)

Standard Diluent Volumes for GHK-Cu Reconstitution

To reconstitute GHK-Cu for laboratory research, the recommended volume of bacteriostatic water generally ranges from 1.0 mL to 5.0 mL per vial depending on the starting mass (typically 50 mg or 100 mg) and desired working concentration. For standard benchtop assays, adding 2.0 mL of bacteriostatic water to a 50 mg vial of GHK-Cu lyophilized powder yields a concentration of 25 mg/mL (25 µg/µL), providing an optimal balance between solubility, fluid volume management, and pipetting accuracy.

Choosing the appropriate volume requires balancing volumetric precision against solution viscosity and storage constraints. Lower diluent volumes (such as 1.0 mL) produce highly concentrated stock solutions suited for high-throughput dilutions, whereas larger diluent volumes (such as 5.0 mL) reduce concentration errors during micro-volumetric transfers in cell culture assays. Researchers can evaluate complete specs across our entire catalog of research peptides to ensure volumetric protocols align with analytical equipment limits.

GHK-Cu Reconstitution Reference Chart

The following reference matrix details the resulting concentration (mg/mL and µg/µL) achieved when reconstituting standard high-purity GHK-Cu laboratory vials across four primary bacteriostatic water fill volumes: 1.0 mL, 2.0 mL, 3.0 mL, and 5.0 mL. These mathematical values assume complete dissolution of the lyophilized cake.

For a 50 mg GHK-Cu vial: Adding 1.0 mL of bacteriostatic water results in 50.0 mg/mL (50.0 µg/µL); adding 2.0 mL results in 25.0 mg/mL (25.0 µg/µL); adding 3.0 mL results in 16.67 mg/mL (16.67 µg/µL); and adding 5.0 mL results in 10.0 mg/mL (10.0 µg/µL).

For a 100 mg GHK-Cu vial: Adding 1.0 mL of bacteriostatic water results in 100.0 mg/mL (100.0 µg/µL); adding 2.0 mL results in 50.0 mg/mL (50.0 µg/µL); adding 3.0 mL results in 33.33 mg/mL (33.33 µg/µL); and adding 5.0 mL results in 20.0 mg/mL (20.0 µg/µL). To quickly adjust for custom concentrations or non-standard vial masses, researchers should utilize our interactive peptide reconstitution calculator.

The Arithmetic of Concentration Calculations

Calculating working concentrations for peptide solutions relies on basic mass-over-volume principles expressed by the formula: C = m / V, where C represents final concentration (mg/mL), m represents total peptide mass (mg), and V represents total diluent volume (mL). Because 1 mg/mL is mathematically equivalent to 1 µg/µL, converting laboratory doses to micro-pipetting volumes for cell culture wells is straightforward.

When preparing secondary working solutions from a stock vial, the dilution formula C1 * V1 = C2 * V2 must be applied. For instance, if an in vitro assay requires a final working concentration of 250 µg/mL in a total volume of 10 mL of culture media, and the primary stock vial is 50 mg reconstituted in 2.0 mL (25 mg/mL), the required stock aliquot (V1) is calculated as: V1 = (0.25 mg/mL * 10 mL) / 25 mg/mL = 0.1 mL (100 µL). Precision micro-pipettes calibrated to ISO standards are required to execute these transfers without introducing volumetric variance.

Physicochemical Properties and Solubilization Mechanics of GHK-Cu

Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring tripeptide-copper complex with a molecular weight of approximately 404.9 g/mol (unbound tripeptide mass ~340.38 g/mol chelated to Cu2+). Due to its hydrophilic amino acid composition and coordinate covalent bonding with divalent copper ions, GHK-Cu exhibits high aqueous solubility compared to hydrophobic signal peptides.

Preclinical studies indicate that the chelated copper ion confers a distinct deep blue coloration to aqueous solutions. During reconstitution with bacteriostatic water (0.9% benzyl alcohol preserved water), gentle swirl mixing is sufficient to achieve complete solubilization within 30 to 60 seconds. High-energy vortexing should be avoided as mechanical shear stress can disrupt non-covalent interactions or induce peptide aggregation. Every batch of PX1 Research GHK-Cu undergoes strict verification, accompanied by a lot-specific COA confirming identity via Mass Spectrometry and mass fraction purity via High-Performance Liquid Chromatography (HPLC).

Preclinical Biological Targets: Collagen, Elastin, and Remodeling

In published preclinical research models, GHK-Cu has been extensively evaluated for its role in extracellular matrix (ECM) synthesis and cellular tissue remodeling. In vitro assays demonstrate that GHK-Cu modulates the transcription of genes responsible for collagen and elastin synthesis, specifically upregulating mRNA expression of type I and type III collagen in dermal fibroblasts.

Furthermore, animal models examining dermal wound closure indicate that GHK-Cu regulates metalloproteinase (MMP) activity and their tissue inhibitors (TIMPs). This dual regulatory mechanism balances collagen deposition with matrix degradation, facilitating organized ECM turnover while suppressing pathways associated with hyperplastic or fibrotic scarring. These properties make GHK-Cu a key benchmark compound in tissue engineering and regenerative biomaterial research.

Comparative Analysis: GHK-Cu vs. GHK Basic and AHK-Cu

Within the broader landscape of tissue remodeling research, investigators frequently compare GHK-Cu against related tripeptides and copper complexes to isolate specific biological mechanisms. Understanding the physical and chemical differences between these compounds is vital for proper diluent volumetric selection and assay design.

When evaluating copper peptide complexes, researchers often compare copper-chelated GHK-Cu with unchelated GHK peptide and AHK-Cu tripeptide. Unchelated GHK lacks the bound divalent copper ion, resulting in a distinct molecular weight (340.38 g/mol) and clear solution upon reconstitution, primarily serving as a control to isolate copper-dependent signal pathways. Conversely, AHK-Cu (Alanine-Histidine-Lysine copper complex) shares structural similarities with GHK-Cu but demonstrates altered binding affinity toward specific vascular growth factor pathways in cell culture models. Both copper complexes require careful volumetric planning to prevent rapid precipitation when combined with high-ionic-strength buffer systems.

Step-by-Step Reconstitution Protocol for In Vitro Assays

Executing a pristine reconstitution protocol within a laminar flow hood minimizes contamination risks and ensures long-term chemical stability. Review our detailed bacteriostatic water guidance for universal laboratory techniques prior to handling lyophilized vials.

1. Sanitize the workspace and wipe the rubber septum of the GHK-Cu vial with a 70% isopropyl alcohol swab. 2. Using a sterile polypropylene syringe fitted with a 21-gauge to 25-gauge needle, draw up the calculated volume of bacteriostatic water (e.g., 2.0 mL). 3. Insert the needle at a 45-degree angle through the center of the rubber stopper, directing the diluent stream against the glass wall of the vial rather than directly onto the lyophilized powder cake. 4. Allow the vacuum equalization to naturally draw the fluid in, adjusting plunger pressure if necessary. 5. Gently invert or roll the vial between your palms until the powder fully dissolves into a clear blue solution. Do not shake or vortex intensely.

Aliquoting Guidance, Storage Stability, and Freeze-Thaw Prevention

Once reconstituted with bacteriostatic water, GHK-Cu solutions maintain chemical stability for up to 28 days when stored at 2°C to 8°C, protected from light. The 0.9% benzyl alcohol preservative inhibits microbial growth during multi-use sampling under aseptic conditions.

For long-term experimental timelines exceeding 30 days, reconstituted stock solutions must be aliquoted into sterile, low-binding polypropylene microcentrifuge tubes (e.g., 100 µL to 500 µL volumes) and stored at -20°C or -80°C. Aliquoting prevents degradation caused by repeated freeze-thaw cycles, which can break down peptide chains and compromise copper chelation. Once an aliquot is thawed for an assay, any unused portion should be discarded or held at 4°C for short-term use only.

PX1 Research Quality Standards: HPLC, MS, and Endotoxin Testing

Experimental integrity depends entirely on the chemical purity and consistency of the starting research material. PX1 Research manufactures all compounds in state-of-the-art, GMP-compliant facilities located in the United States, adhering strictly to ISO 17025 laboratory testing standards.

Every production lot of GHK-Cu undergoes complete characterization via High-Performance Liquid Chromatography (HPLC) to guarantee ≥98% purity, alongside Mass Spectrometry (MS) to verify molecular structure and chelation integrity. Furthermore, critical cell-culture applications require low endotoxin levels; our compounds undergo Chromogenic LAL testing to confirm endotoxin levels fall well below rigorous threshold limits (<0.05 EU/mg). Institutions managing high-volume screening protocols can establish a bulk research account to access raw data files, analytical certificates, and volume supply arrangements.

Laboratory Best Practices for Handling Reconstituted Copper Peptides

When designing protocols involving copper peptides, researchers must account for buffer interactions and light exposure. Direct exposure to intense ultraviolet light can accelerate photolytic degradation of the peptide backbone. Reconstituted vials should be stored in opaque containers or wrapped in aluminum foil during benchtop procedures.

Additionally, mixing copper peptides directly with strong chelating agents (such as EDTA) or strong reducing agents (such as dithiothreitol or ascorbic acid) in stock solutions can strip the copper ion from the tripeptide core, fundamentally altering experimental outcomes. For comprehensive technical background on secondary assays and tissue remodeling markers, explore the PX1 research library.